<code id='ABDA2DCDCF'></code><style id='ABDA2DCDCF'></style>
    • <acronym id='ABDA2DCDCF'></acronym>
      <center id='ABDA2DCDCF'><center id='ABDA2DCDCF'><tfoot id='ABDA2DCDCF'></tfoot></center><abbr id='ABDA2DCDCF'><dir id='ABDA2DCDCF'><tfoot id='ABDA2DCDCF'></tfoot><noframes id='ABDA2DCDCF'>

    • <optgroup id='ABDA2DCDCF'><strike id='ABDA2DCDCF'><sup id='ABDA2DCDCF'></sup></strike><code id='ABDA2DCDCF'></code></optgroup>
        1. <b id='ABDA2DCDCF'><label id='ABDA2DCDCF'><select id='ABDA2DCDCF'><dt id='ABDA2DCDCF'><span id='ABDA2DCDCF'></span></dt></select></label></b><u id='ABDA2DCDCF'></u>
          <i id='ABDA2DCDCF'><strike id='ABDA2DCDCF'><tt id='ABDA2DCDCF'><pre id='ABDA2DCDCF'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:4
          Paul Hudson -- biotech coverage from STAT
          Sanofi CEO Paul Hudson Courtesy Sanofi

          NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their decision to reduce earnings forecasts for 2024 in order to fund more research studies of new medicines they say could one day generate billions of dollars in annual sales.

          CEO Paul Hudson and Houman Ashrafian, Sanofi’s new head of R&D, made their remarks in an exclusive interview with STAT ahead of a full-day meeting with analysts here. When the cuts to earnings were first announced Oct. 27, along with a plan to spin off the company’s consumer products division, shares dove 18% and have yet to fully recover. The share price is down 5% since the beginning of 2023.

          advertisement

          “I’ve been waiting four years for a situation where we could put [out] the pipeline, as impressive as it is, and declare that we’re going to be the world’s leading immunology company,” said Hudson, who took over as CEO in 2019. “So it’s quite an important moment for us. And it’s an important moment to declare that we’re back in science, because I could argue that we haven’t been where we needed to be.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Traditional Chinese medicine benefits explored in new JAMA study
          Traditional Chinese medicine benefits explored in new JAMA study

          STR/AFPviaGettyImagesAtraditionalChinesemedicinecompoundusedforcardiacbenefitsmighthelpreducetheinci

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Chimpanzees, like humans and whales, get menopause: Study

          GUERCHOMNDEBO/AFPviaGettyImagesChimpanzees—they’rejustlikeus.Femalechimps,itturnsout,gothroughmenopa